goto Index (07.05.03/07.29.05)
DrTim homepage link
Outline and Commentary on the 2002 Proceedings
by Timothy D. Bilash MD, MS, OBGYN
June 2003
www.DrTimDelivers.com
from
H.A. Risch [MHC CH 15]
Department of Epidemiology and Public Health
Yale University School of Medicine
60 College Street, P.O. Box 208034
New Haven, CT 06520-8034
USA
- Androgens
- plasma estrone is produced by adipose aromatization of androstenedione, about half of which is ovarian, and half adrenal in younger women
- Breast and ovarian epithelial cells express 17B-hydroxysteroid dehydrogenase (17BHSD), which converts Androstenedione to Testosterone (and Estrone to Estradiol)
- Androstenedione is a weak androgen, which does not bind strongly to Ar Androgen receptor
- converted in epithelial cells to testosterone, which does bind to Ar
- Plasma levels of androgens are greater than those of estrogens, even during the late follicular phase of the menstural cycle when estrogen levels are highest.
- Androgens may stimulate epithelial cell proliferation
- Testosterone stimulates ovarian epithelium
- epidemiology supports the association between androgens and risk of ovarian cancer
goto CH 1
goto Index
goto www.DrTimDelivers.com
page views since Sept2007